https://www.selleckchem.com/pr....oducts/ly3295668.htm
Understanding these associations may pave ways for novel potential adjunct intervention in gut microbiota in CCA patients. Thetanix (gastroresistant capsules containing lyophilized Bacteroides thetaiotaomicron) is a live biotherapeutic, under development for Crohn's disease, that antagonizes transcription factor nuclear factor kappa B, reducing proinflammatory cytokines, particularly tumor necrosis factor alpha. We aimed to assess safety and tolerability in adolescents with Crohn's disease in remission. Subjects who were 16-18 years w
Like
Comment
Share
